These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22761385)

  • 1. Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and vesicular stomatitis virus to neutralization.
    Johnson JB; Lyles DS; Alexander-Miller MA; Parks GD
    J Virol; 2012 Sep; 86(18):9929-40. PubMed ID: 22761385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.
    Johnson JB; Grant K; Parks GD
    J Virol; 2009 Aug; 83(15):7602-11. PubMed ID: 19457998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Dissection of the Dominant Role of CD55 in Protecting Vesicular Stomatitis Virus against Complement-Mediated Neutralization.
    Asok Kumar N; Muraleedharan Suma S; Kunnakkadan U; Nag J; Koolaparambil Mukesh R; Lyles DS; Johnson JB
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33652918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization.
    Li Y; Johnson JB; Parks GD
    Virology; 2016 Oct; 497():305-313. PubMed ID: 27505156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
    Li Y; Parks GD
    Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion.
    Biswas M; Johnson JB; Kumar SR; Parks GD; Elankumarana S
    J Virol; 2012 Dec; 86(23):12708-16. PubMed ID: 22973037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of CD55 and CD46 expression by anti-sense phosphorothioate oligonucleotides (S-ODNs) sensitizes tumour cells to complement attack.
    Zell S; Geis N; Rutz R; Schultz S; Giese T; Kirschfink M
    Clin Exp Immunol; 2007 Dec; 150(3):576-84. PubMed ID: 17903221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virus.
    Ayala-Breton C; Russell LO; Russell SJ; Peng KW
    J Virol; 2014 Aug; 88(15):8332-9. PubMed ID: 24829351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
    Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
    Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64.
    Kaname Y; Tani H; Kataoka C; Shiokawa M; Taguwa S; Abe T; Moriishi K; Kinoshita T; Matsuura Y
    J Virol; 2010 Apr; 84(7):3210-9. PubMed ID: 20071581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation.
    Christiansen D; Loveland B; Kyriakou P; Lanteri M; Rubinstein E; Gerlier D
    Mol Immunol; 2000; 37(12-13):687-96. PubMed ID: 11275254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus.
    Johnson JB; Capraro GA; Parks GD
    Virology; 2008 Jun; 376(1):112-23. PubMed ID: 18440578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting complement activation on cells at the step of C3 cleavage.
    Liszewski MK; Fang CJ; Atkinson JP
    Vaccine; 2008 Dec; 26 Suppl 8(Suppl 8):I22-7. PubMed ID: 19388160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
    Brodbeck WG; Mold C; Atkinson JP; Medof ME
    J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
    Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
    J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack.
    Kesselring R; Thiel A; Pries R; Fichtner-Feigl S; Brunner S; Seidel P; Bruchhage KL; Wollenberg B
    Eur J Cancer; 2014 Aug; 50(12):2152-61. PubMed ID: 24915776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.
    Saifuddin M; Hedayati T; Atkinson JP; Holguin MH; Parker CJ; Spear GT
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1907-11. PubMed ID: 9266986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).
    Manchester M; Valsamakis A; Kaufman R; Liszewski MK; Alvarez J; Atkinson JP; Lublin DM; Oldstone MB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2303-7. PubMed ID: 7534417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.
    Kwon YC; Kim H; Meyer K; Di Bisceglie AM; Ray R
    J Immunol; 2016 Aug; 197(4):1127-36. PubMed ID: 27357152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation.
    van Beek J; van Meurs M; 't Hart BA; Brok HP; Neal JW; Chatagner A; Harris CL; Omidvar N; Morgan BP; Laman JD; Gasque P
    J Immunol; 2005 Feb; 174(4):2353-65. PubMed ID: 15699172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.